• pulmonary arterial hypertension pipeline outlook report 2025: openPR.com Sun, 26 Oct 2025 07:00:00 GMT
• short bowel syndrome pipeline drugs insights report 2025: openPR.com Wed, 15 Oct 2025 12:36:06 GMT
• Monoclonal Gammopathy of Undetermined Significance (MGUS) Management Market Future Market Insights Thu, 04 Sep 2025 07:00:00 GMT
• short bowel syndrome pipeline outlook 2025: clinical trial openPR.com Fri, 29 Aug 2025 16:28:03 GMT
• why i've started a small short in phasebio pharmaceuticals (otcmkts:phasq) Seeking Alpha Fri, 29 Aug 2025 01:56:10 GMT
• achondroplasia treatment market on track for massive expansion by 2035, forecasts reveal. newstrail.com Tue, 19 Aug 2025 19:34:10 GMT
• diagonal therapeutics appoints john lee, m.d., ph.d., as chief medical officer GlobeNewswire Tue, 08 Jul 2025 07:00:00 GMT
• Phio Pharmaceuticals Advances 30-Drug Cancer Portfolio as Phase 1b Trial Shows Promise Stock Titan Fri, 06 Jun 2025 07:00:00 GMT
• phio pharmaceuticals announces strategic initiative to create awareness of the comprehensive intasyl sirna portfolio Newsfile Fri, 06 Jun 2025 07:00:00 GMT
• uncontrolled bleeding treatment market size in 7mm is expected to grow at a decent cagr by 2032, estimates delveinsight The Globe and Mail Mon, 12 May 2025 23:02:00 GMT
• global restrictive cardiomyopathy treatment market to surpass usd 195.5 million by 2035 | fmi newstrail.com Tue, 29 Apr 2025 07:00:00 GMT
• monoclonal antibody bentracimab shown to reverse antiplatelet effect of brilinta | acc 2025 Managed Healthcare Executive Tue, 01 Apr 2025 07:00:00 GMT
• soul: oral semaglutide cuts mace by 14% in people with type 2 diabetes MD Magazine Sat, 29 Mar 2025 18:37:08 GMT
• oral semaglutide cuts cardiovascular risk by 14% in soul trial AJMC.com Managed Markets Network Sat, 29 Mar 2025 18:32:24 GMT
• REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects HCPLive Sat, 29 Mar 2025 07:00:00 GMT
• ticagrelor antidote safely, effectively restores platelet function and treats bleeding American College of Cardiology Sat, 29 Mar 2025 07:00:00 GMT
• bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events News-Medical Sat, 29 Mar 2025 07:00:00 GMT
• stride: semaglutide shows it has legs in peripheral artery disease MedPage Today Sat, 29 Mar 2025 07:00:00 GMT
• ticagrelor antidote bentracimab safely reverses antiplatelet effects in phase 3 reverse-it trial AJMC Sat, 29 Mar 2025 07:00:00 GMT
• pulmonary arterial hypertension clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and com... The Globe and Mail Wed, 12 Mar 2025 18:37:18 GMT
• duke university professor ashutosh chilkoti honored with 2025 technology innovation and development award by the society for bioma... The Indian EYE Wed, 19 Feb 2025 08:00:00 GMT
• global transmucosal drugs market to reach ~usd 28 billion by 2032 | delveinsight PR Newswire Tue, 18 Feb 2025 08:00:00 GMT
• pulmonary arterial hypertension clinical trials and studies: ema, pdma, fda approvals, mechanism of action, EIN News Thu, 13 Feb 2025 12:26:00 GMT
• medpharm appoints bill humphries as chief executive officer to lead next phase of strategic growth PR Newswire Tue, 04 Feb 2025 08:00:00 GMT
• advancements in ocular hypertension clinical trial pipeline GlobeNewswire Tue, 21 Jan 2025 06:46:25 GMT
• heart failure with reduced ejection fraction market to expand significantly by 2032, states delveinsight EIN News Mon, 20 Jan 2025 21:10:00 GMT
• advancements in ocular hypertension clinical trial pipeline GlobeNewswire Mon, 20 Jan 2025 08:00:00 GMT
• why i've started a small short in phasebio pharmaceuticals (otcmkts:phasq) Seeking Alpha Tue, 07 Jan 2025 20:43:16 GMT
• The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender MedCity News Thu, 26 Dec 2024 08:00:00 GMT
• acute heart failure (ahf) therapeutics market report overview Business Research Insights Mon, 23 Dec 2024 08:00:00 GMT
• johnson & johnson innovation – jjdc - investor profile, portfolio & team Tracxn Mon, 02 Dec 2024 08:00:00 GMT
• phasq (phasebio pharmaceuticals) other current assets : $3.76 mil (as of jun. 2022) GuruFocus.com Thu, 28 Nov 2024 04:31:28 GMT
• as top investor makes its play to grab lead drug, phasebio counters with chapter 11, stalking-horse bid Endpoints News Sat, 26 Oct 2024 07:00:00 GMT
• philadelphia-area life sciences industry nears 900 layoffs since 2022 BioBuzz Fri, 18 Oct 2024 07:00:00 GMT
• philadelphia-area life sciences industry nears 900 layoffs since 2022 The Business Journals Fri, 11 Oct 2024 07:00:00 GMT
• barriers and facilitators to implementation of intravenous cardiovascular treatments in ambulatory settings Wiley Online Library Wed, 25 Sep 2024 07:00:00 GMT
• acute heart failure (ahf) therapeutics industry size, share, price, trends, forecast (2024-2034) Third Eye News Mon, 23 Sep 2024 08:23:02 GMT
• head-to-head analysis: evolus (nasdaq:eols) & phasebio pharmaceuticals (nasdaq:phas) Defense World Mon, 26 Aug 2024 05:43:27 GMT
• phasq (phasebio pharmaceuticals) ev-to-revenue : -1.19 (as of aug. 16, 2024) GuruFocus.com Sat, 17 Aug 2024 02:28:20 GMT
• phasebio reports monthly operating results amid bankruptcy by investing.com Investing.com Australia Fri, 16 Aug 2024 14:22:21 GMT
• phasebio reports monthly operating results amid bankruptcy Investing.com Thu, 15 Aug 2024 21:56:15 GMT
• achondroplasia market is expected to show a significant growth during the forecast period | pfizer, sanofi, prolynx, phasebio, asc... Barchart.com Thu, 15 Aug 2024 07:00:00 GMT
• acute respiratory distress syndrome market size in 7mm was ~usd 941 million in 2023, asserts delveinsight | medicinova, edesa biot... Barchart.com Tue, 30 Jul 2024 07:00:00 GMT
• short bowel syndrome market positive outlook: phase bio , orphan technologies , zealand pharma Newstrail Sat, 27 Jul 2024 07:00:00 GMT
• lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes mellitus: the mass general brigham lp(a) r... Cardiovascular Diabetology Thu, 18 Jul 2024 07:00:00 GMT
• phasebio announces bankruptcy plan confirmation by investing.com Investing.com Australia Sat, 13 Jul 2024 07:00:00 GMT
• jefferies upgrades cooper companies stock to 'buy', highlights growth prospects by investing.com Investing.com Fri, 12 Jul 2024 23:00:19 GMT
• phasebio explodes 82% after-hours on fda nod for covid-19 clinical trial TipRanks Thu, 04 Jul 2024 10:39:12 GMT
• pentixapham acquires antibody discovery business from glycotope Pharmaceutical Technology Thu, 04 Jul 2024 07:00:00 GMT
• sanotize appoints john sharp as chief financial officer World Business Outlook Sun, 23 Jun 2024 10:03:13 GMT
• achondroplasia pipeline analysis 2024: fda approvals and emerging therapies | ascendis pharma, bridgebio ... Barchart Thu, 20 Jun 2024 13:23:00 GMT
• phasebio pharmaceuticals, inc. (phas) shares march higher, can it continue? Yahoo Movies UK Tue, 18 Jun 2024 07:41:47 GMT
• phasebio announces bankruptcy plan confirmation by investing.com Investing.com Fri, 14 Jun 2024 07:00:00 GMT
• strong week for phasebio pharmaceuticals (nasdaq:phas) shareholders doesn't alleviate pain of three-year loss Yahoo New Zealand News Wed, 29 May 2024 23:54:40 GMT
• acute liver failure treatment market size, outlook, swot & forecast 2033 Verified Market Reports Thu, 23 May 2024 11:28:14 GMT
• financial comparison: q32 bio (nasdaq:qttb) vs. phasebio pharmaceuticals (nasdaq:phas) Defense World Wed, 15 May 2024 07:00:00 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Fri, 10 May 2024 05:23:06 GMT
• ers international congress 2016 - cardio-vascular, one to watch companies The Pharma Letter Wed, 08 May 2024 21:48:34 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Sun, 05 May 2024 12:00:01 GMT
• do options traders know something about phasebio pharmaceuticals (phas) stock we don't? Yahoo New Zealand News Sat, 04 May 2024 22:45:59 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Sat, 04 May 2024 13:05:12 GMT
• phasebio pharma (phas) reports q2 loss, lags revenue estimates Yahoo Canada Shine On Fri, 03 May 2024 20:53:00 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Fri, 03 May 2024 14:11:22 GMT
• effect of reconstituted human apolipoprotein a-i on recurrent ischemic events in survivors of acute mi ScienceDirect.com Fri, 03 May 2024 12:48:40 GMT
• did you manage to avoid phasebio pharmaceuticals's (nasdaq:phas) 21% share price drop? Yahoo Movies UK Mon, 29 Apr 2024 05:12:43 GMT
• chutes & ladders—top bio lobbyist quickly exits after biosecure reversal Fierce Biotech Fri, 12 Apr 2024 07:00:00 GMT
• Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer PR Newswire Thu, 11 Apr 2024 07:00:00 GMT
• Treatment-Resistant Hypertension Market is Anticipated to GlobeNewswire Tue, 09 Apr 2024 07:00:00 GMT
• effect of reconstituted human apolipoprotein a-i on recurrent ischemic events in survivors of acute mi JACC Journals Sat, 06 Apr 2024 07:00:00 GMT
• reviewing immunoprecise antibodies (nasdaq:ipa) & phasebio pharmaceuticals (nasdaq:phas) Defense World Mon, 01 Apr 2024 05:53:00 GMT
• short bowel syndrome market size in the 7mm was ~usd 2300 million in 2023, estimated delveinsight WICZ Sun, 31 Mar 2024 07:00:00 GMT
• impahct: a randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension Wiley Online Library Mon, 25 Mar 2024 07:00:00 GMT
• acute heart failure (ahf) therapeutics global strategic GlobeNewswire Fri, 01 Mar 2024 08:00:00 GMT
• phasebio pharmaceuticals (nasdaq:phas) versus united therapeutics (nasdaq:uthr) critical analysis AmericanBankingNEWS Wed, 28 Feb 2024 11:20:44 GMT
• united therapeutics (nasdaq:uthr) and phasebio pharmaceuticals (nasdaq:phas) critical analysis Defense World Wed, 28 Feb 2024 11:19:22 GMT
• pulmonary arterial hypertension market to witness growth by 2032, estimates delveinsight | merck, united ... Coin Plus（コインプラス） Wed, 28 Feb 2024 07:46:34 GMT
• goldilocks and the 'not great, but good enough': drug development shops offer 'sweet spot' deal alternative Fierce Biotech Tue, 27 Feb 2024 08:00:00 GMT
• achondroplasia treatment market projected to reach usd 3.2 GlobeNewswire Thu, 01 Feb 2024 08:00:00 GMT
• resistant hypertension therapeutics market see huge growth for new normal | bayer ag, novartis ag, sarfez ... Future of Media Thu, 11 Jan 2024 21:57:27 GMT
• achondroplasia treatment drug market to register positive growth by 2032, assesses delveinsight | key companies in the market - as... PR Newswire Tue, 09 Jan 2024 08:00:00 GMT
• acute heart failure (ahf) therapeutics market size, overview, potential & forecast 2033 Verified Market Reports Tue, 02 Jan 2024 03:00:04 GMT
• pulmonary arterial hypertension market forecast 2024-2030: advancements in cardiovascular care WhaTech Thu, 28 Dec 2023 08:00:00 GMT
• cardiomyopathy medication market (2023-2029):pfizer, phasebio pharmaceuticals, astrazeneca, roche, johnson ... Artrocker Wed, 13 Dec 2023 05:21:56 GMT
• pulmonary arterial hypertension pipeline and clinical trials ... Digital Journal Mon, 04 Dec 2023 19:49:11 GMT
• csl (otcmkts:cslly) and phasebio pharmaceuticals (nasdaq:phas) critical survey Defense World Mon, 04 Dec 2023 08:00:00 GMT
• an explainable machine learning-based phenomapping strategy for ... Nature.com Sat, 25 Nov 2023 08:00:00 GMT
• ocular hypertension market size and share to increase by GlobeNewswire Wed, 22 Nov 2023 08:00:00 GMT
• phasebio pharmaceuticals, inc. – with debtor still locking horns with sfj (this time over a contested $9.6mn ... Bankrupt Company News Fri, 10 Nov 2023 08:00:00 GMT
• phasebio pharmaceuticals, inc. – with debtor still locking horns with sfj (this time over a contested $9.6mn ... Bankrupt Company News Wed, 08 Nov 2023 23:48:38 GMT
• 4e brands northamerica llc – u.s. trustee, citing "foundational ... Bankrupt Company News Fri, 03 Nov 2023 07:00:00 GMT
• pulmonary arterial hypertension pipeline insights report 2023 (updated) openPR.com Thu, 02 Nov 2023 07:00:00 GMT
• efficacy of sotagliflozin in adults with type 2 diabetes in relation to baseline hemoglobin a1c ScienceDirect.com Mon, 30 Oct 2023 18:55:25 GMT
• revascularization after treatment of in-stent restenosis high after 10 ... Healio Fri, 27 Oct 2023 07:00:00 GMT
• sustained mitral regurgitation reduction for high-risk patients with ... Healio Thu, 26 Oct 2023 07:00:00 GMT
• directbuy home improvement, inc. – home furnishings company ... Bankrupt Company News Tue, 17 Oct 2023 07:00:00 GMT
• twist bioscience and bayer partner for antibody discovery Pharmaceutical Technology Fri, 06 Oct 2023 07:00:00 GMT
• twist bioscience, bayer partner for antibody discovery Pharmaceutical Technology Fri, 06 Oct 2023 07:00:00 GMT
• zymergen inc. – boston-based ginkgo bioworks puts onetime ... Bankrupt Company News Tue, 03 Oct 2023 07:00:00 GMT
• barretts minerals inc. – montana talc mine operators, subsidiaries ... Bankrupt Company News Mon, 02 Oct 2023 07:00:00 GMT
• dr seun ross: bcbs health equity goals across 4 focus areas AJMC.com Managed Markets Network Thu, 28 Sep 2023 07:00:00 GMT
• bivalirudin versus heparin during pci in nstemi: individual patient ... AHA Journals Mon, 25 Sep 2023 07:00:00 GMT
• noble house home furnishings, llc – e-commerce/big box ... Bankrupt Company News Tue, 12 Sep 2023 07:00:00 GMT
• soft surroundings holdings, llc – women's apparel and soft ... Bankrupt Company News Mon, 11 Sep 2023 07:00:00 GMT
• compound in beetroot juice fends off contrast-induced aki Medpage Today Tue, 29 Aug 2023 07:00:00 GMT
• stopdapt-3: skipping aspirin after pci does not reduce bleeding ... Healio Tue, 29 Aug 2023 07:00:00 GMT
• semaglutide in hfpef across obesity class and by body weight ... Nature.com Sun, 27 Aug 2023 07:00:00 GMT
• biodegradable-polymer or durable-polymer stents in patients at ... AHA Journals Fri, 25 Aug 2023 07:00:00 GMT
• avoid using prasugrel with cangrelor during pci, swap-6 affirms TCTMD Tue, 22 Aug 2023 07:00:00 GMT
• pulmonary arterial hypertension market size is expected to reach us$ 8.76 bn by 2029 Newstrail Fri, 18 Aug 2023 07:00:00 GMT
• patients with diabetes, worsening hf benefit from sotagliflozin at or ... Healio Mon, 14 Aug 2023 07:00:00 GMT
• effect of sotagliflozin on early mortality and heart failure-related events: a post hoc analysis of soloist-whf JACC Journals Mon, 07 Aug 2023 07:00:00 GMT
• left-sided valvular heart disease and survival in out-of-hospital ... Nature.com Fri, 04 Aug 2023 07:00:00 GMT
• surge transportation, inc. – specialist, premium-priced freight ... Bankrupt Company News Tue, 25 Jul 2023 07:00:00 GMT
• chutes & ladders—stanford president resigns after investigation Fierce Biotech Fri, 21 Jul 2023 07:00:00 GMT
• triumvira immunologics strengthens its leadership team with three accomplished life sciences executives PR Newswire Thu, 20 Jul 2023 07:00:00 GMT
• hypertension market to accelerate positively, estimates delveinsight | key companies active in the market - novartis, bayer, merck... PR Newswire Wed, 19 Jul 2023 07:00:00 GMT
• cullen drescher speckhart - partner in charge – washington, dc Cooley Wed, 12 Jul 2023 00:12:13 GMT
• graft failure after coronary artery bypass grafting and its ... AHA Journals Fri, 07 Jul 2023 07:00:00 GMT
• imedia brands, inc. – media company "capitalizing on the ... Bankrupt Company News Thu, 29 Jun 2023 07:00:00 GMT
• gene therapy developer swanbio to narrow research focus, lay off half its workforce The Business Journals Thu, 29 Jun 2023 07:00:00 GMT
• the fgf21 analog pegozafermin in severe hypertriglyceridemia: a ... Nature.com Sat, 24 Jun 2023 07:00:00 GMT
• Chutes & Ladders—Bayer promotes Sebastian Guth to helm all US operations Fierce Biotech Fri, 23 Jun 2023 07:00:00 GMT
• sebastian guth sharpens his focus at bayer; as cd47 struggles persist, i-mab appoints ceo Endpoints News Fri, 23 Jun 2023 07:00:00 GMT
• veralox names phasebio’s jonathan mow as new ceo after raising $24 million citybiz Fri, 23 Jun 2023 07:00:00 GMT
• around the house: former star wars lawyer named surf air legal chief, empower ai adds gc in newly created role The Global Legal Post Fri, 23 Jun 2023 07:00:00 GMT
• veralox names phasebio's jonathan mow as new ceo after raising $24 million citybiz Fri, 23 Jun 2023 07:00:00 GMT
• sebastian guth takes reins of bayer's us operations—chutes ... FierceBiotech Fri, 23 Jun 2023 07:00:00 GMT
• considerations on the management of acute postoperative ... AHA Journals Thu, 22 Jun 2023 07:00:00 GMT
• frederick, maryland based veralox therapeutics appoints jonathan mow as ceo and announces $24 million in new funding BioBuzz Tue, 20 Jun 2023 14:06:45 GMT
• maplight therapeutics appoints kris hanson as general counsel PR Newswire Tue, 20 Jun 2023 07:00:00 GMT
PhaseBio Pharmaceuticals, Inc(NASDAQ:PHAS) 
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiopulmonary diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical ...
Website: http://www.phasebio.com
Founded: 2002
Full Time Employees: 50 (May 2021)
Sector: Healthcare
Industry: Biotechnology